透瘤的淋巴细胞:一个新的希望
Amod A Sarnaik1, Patrick Hwu1, James J Mulé1
1Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Cutaneous Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Cancer cell
|July 19, 2024
概括
瘤透淋巴细胞 (TILs) 为晚期癌症提供细胞疗法,从患者的瘤扩散. 本综述涵盖了TIL治疗的发展,并解决了改善耐火性癌症治疗的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 瘤透淋巴细胞 (TILs) 是已经迁移到瘤组织中的淋巴细胞.
- 可以将TILs扩展到ex vivo,并重新注入患者以治疗癌症.
- 目前的TIL治疗包括化疗和互白素-2,在晚期恶性瘤中显示出前景.
研究的目的:
- 审查TIL治疗的历史发展.
- 讨论当前的挑战和改善TIL治疗疗效的潜在解决方案.
- 突出TILs作为耐火性晚期癌症治疗的潜力.
主要方法:
- 关于TIL疗法的历史发展和临床应用的文献综述.
- 分析TIL治疗当前的障碍,包括制造和临床管理.
- 讨论潜在的策略,以克服这些挑战,并提高治疗结果.
主要成果:
- TIL疗法已经显著发展,在选择的晚期癌症中显示出有效性.
- 关键的挑战包括一致的制造,患者选择和优化调节方案.
- 潜在的解决方案包括新的扩张技术,改进的免疫调节和组合策略.
结论:
- TIL疗法代表了对先进的,治疗不耐药的癌症的有前途的方法.
- 解决目前的局限性对于更广泛的临床应用和改善患者存活率至关重要.
- 需要进行进一步的研究和开发,以优化TIL疗法,使其适用于更广泛的患者群体.
相关概念视频
01:27Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K